| __timestamp | Amphastar Pharmaceuticals, Inc. | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 159205000 | 54823000000 |
| Thursday, January 1, 2015 | 174172000 | 76691000000 |
| Friday, January 1, 2016 | 150976000 | 87477000000 |
| Sunday, January 1, 2017 | 149380000 | 89052000000 |
| Monday, January 1, 2018 | 187681000 | 100745000000 |
| Tuesday, January 1, 2019 | 190434000 | 91915000000 |
| Wednesday, January 1, 2020 | 206506000 | 95905000000 |
| Friday, January 1, 2021 | 238029000 | 104442000000 |
| Saturday, January 1, 2022 | 250127000 | 104437000000 |
| Sunday, January 1, 2023 | 293274000 | 112009000000 |
| Monday, January 1, 2024 | 121134000000 |
Unleashing insights
In the ever-evolving landscape of the pharmaceutical and retail sectors, understanding cost dynamics is crucial. Walgreens Boots Alliance, Inc., a retail giant, and Amphastar Pharmaceuticals, Inc., a niche pharmaceutical player, present a fascinating contrast in cost of revenue trends from 2014 to 2023. Over this period, Walgreens Boots Alliance saw a steady increase in its cost of revenue, peaking at approximately 112 billion in 2023, marking a 104% rise from 2014. In contrast, Amphastar Pharmaceuticals experienced a more modest growth, with its cost of revenue increasing by about 84% to nearly 293 million in 2023. This divergence highlights the scale and operational differences between a global retail leader and a specialized pharmaceutical firm. Notably, data for Amphastar in 2024 is missing, underscoring the challenges in forecasting for smaller entities. These insights offer a window into the strategic financial maneuvers of these companies.
Analyzing Cost of Revenue: Johnson & Johnson and Amphastar Pharmaceuticals, Inc.
Cost of Revenue Trends: Sanofi vs Amphastar Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Limited vs Walgreens Boots Alliance, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for United Therapeutics Corporation and Walgreens Boots Alliance, Inc.
Analyzing Cost of Revenue: Walgreens Boots Alliance, Inc. and Perrigo Company plc
Walgreens Boots Alliance, Inc. vs Geron Corporation: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Walgreens Boots Alliance, Inc. vs Dyne Therapeutics, Inc.
Cost of Revenue Comparison: Walgreens Boots Alliance, Inc. vs Viridian Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Veracyte, Inc. vs Amphastar Pharmaceuticals, Inc.
Cost Insights: Breaking Down Xenon Pharmaceuticals Inc. and Amphastar Pharmaceuticals, Inc.'s Expenses
MorphoSys AG vs Amphastar Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Amphastar Pharmaceuticals, Inc. and Evotec SE